We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Banner Corp
BANR
$2.4B
| $1.41M | ﹤0.01% |
30,709
+440
| +1% | +$19K |
|
1652
MasTec
MTZ
$20.9B
| $1.41M | ﹤0.01% |
73,032
+8,350
| +13% | +$167K |
|
|
OSG
1653
Octave Specialty Group
OSG
$255M
| $1.41M | ﹤0.01% |
58,136
+400
| +0.7% | +$10.2K |
|
|
AFFX
1654
DELISTED
Affymetrix Inc
AFFX
| $1.4M | ﹤0.01% |
111,513
+5,550
| +5% | +$64.4K |
|
1655
Bladex Inc
BLX
$2.17B
| $1.38M | ﹤0.01% |
42,192
-15,200
| -26% | -$463K |
|
1656
AMERISAFE
AMSF
$551M
| $1.38M | ﹤0.01% |
29,889
+900
| +3% | +$38.1K |
|
1657
Boyd Gaming
BYD
$6.12B
| $1.38M | ﹤0.01% |
97,336
+10,440
| +12% | +$144K |
|
1658
PetMed Express
PETS
$41.9M
| $1.38M | ﹤0.01% |
83,587
-13,100
| -14% | -$203K |
|
|
UCB
1659
United Community Banks
UCB
$4.29B
| $1.38M | ﹤0.01% |
73,095
+1,500
| +2% | +$27.7K |
|
1660
FerroAtlántica
GSM
$779M
| $1.38M | ﹤0.01% |
72,765
+10,550
| +17% | +$178K |
|
1661
Tompkins Financial
TMP
$1.44B
| $1.37M | ﹤0.01% |
25,418
+1,100
| +5% | +$57.9K |
|
1662
Materion
MTRN
$5.76B
| $1.37M | ﹤0.01% |
35,580
+1,650
| +5% | +$59.3K |
|
1663
Super Micro Computer
SMCI
$19.3B
| $1.37M | ﹤0.01% |
411,560
+77,000
| +23% | +$283K |
|
1664
Encore Capital Group
ECPG
$2.09B
| $1.36M | ﹤0.01% |
32,751
+2,225
| +7% | +$92.4K |
|
1665
SFL Corp
SFL
$1.62B
| $1.36M | ﹤0.01% |
91,906
+3,050
| +3% | +$45.3K |
|
|
CIR
1666
DELISTED
CIRCOR International, Inc
CIR
| $1.36M | ﹤0.01% |
24,829
+1,825
| +8% | +$96.9K |
|
1667
Nordic American Tanker
NAT
$1.36B
| $1.35M | ﹤0.01% |
114,697
-2,016
| -2% | -$21.3K |
|
|
ACHN
1668
DELISTED
Achillion Pharmaceuticals
ACHN
| $1.35M | ﹤0.01% |
137,352
+19,730
| +17% | +$246K |
|
|
ILG
1669
DELISTED
ILG, Inc Common Stock
ILG
| $1.35M | ﹤0.01% |
51,488
+4,700
| +10% | +$116K |
|
1670
Tidewater
TDW
$4.08B
| $1.35M | ﹤0.01% |
2,184
+102
| +5% | +$90.7K |
|
1671
Banco Santander
SAN
$210B
| $1.35M | ﹤0.01% |
190,677
+2,672
| +1% | +$18.1K |
|
|
MDR
1672
DELISTED
McDermott International
MDR
| $1.35M | ﹤0.01% |
117,004
+6,144
| +6% | +$52.7K |
|
1673
Innoviva
INVA
$1.57B
| $1.35M | ﹤0.01% |
85,711
+10,905
| +15% | +$165K |
|
1674
Virtus Investment Partners
VRTS
$1.09B
| $1.35M | ﹤0.01% |
10,298
+1,061
| +11% | +$150K |
|
|
ARIA
1675
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $1.34M | ﹤0.01% |
163,263
+26,075
| +19% | +$193K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.